Phi Therapeutics (California) Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
14
Phi Therapeutics (California) General Information
Description
Operator of a skincare product platform intended to treat acne. The company utilizes microbiome and bacteriophage technology to target acne-causing bacteria while preserving beneficial skin microbiota, enabling customers to access acne treatment without disrupting skin health.
Contact Information
Website
www.phyla.comCorporate Office
- 1250 Petaluma Boulevard North
- Petaluma, CA 94952
- United States
Corporate Office
- 1250 Petaluma Boulevard North
- Petaluma, CA 94952
- United States
Phi Therapeutics (California) Timeline
Phi Therapeutics (California) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Later Stage VC (Series A) | 26-Jun-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 07-Dec-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 12-Jan-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 04-Jun-2019 | Completed | Generating Revenue | |||
| 2. Grant | 05-Sep-2015 | $165K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Startup |
Phi Therapeutics (California) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 2,556,028 | $0.001000 | 8% | $1.96 | $1.96 | 1x | $1.96 | 9.28% |
| Seed | 1,805,773 | $0.001000 | 8% | $0.87 | $0.87 | 1x | $0.87 | 21.86% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Phi Therapeutics (California) Comparisons
Industry
Financing
Details
Phi Therapeutics (California) Competitors (9)
One of Phi Therapeutics (California)’s 9 competitors is Dermala, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dermala | Venture Capital-Backed | San Diego, CA | ||||
| Oskia Skincare | Corporation | London, United Kingdom | ||||
| AHAVA | Formerly PE-Backed | Airport City, Israel | ||||
| It Cosmetics | Formerly PE-Backed | Westfield, NJ | ||||
| La Roche Posay | Formerly PE-Backed | La Roche-Posay, France |
Phi Therapeutics (California) Patents
Phi Therapeutics (California) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024252638-A1 | Compositions and methods for the treatment of skin diseases and conditions including eczema | Pending | 03-Apr-2023 | ||
| EP-4687933-A2 | Compositions and methods for the treatment of skin diseases and conditions including eczema | Pending | 03-Apr-2023 | ||
| US-12605416-B2 | Compositions and methods for the treatment of skin diseases and conditions including eczema | Active | 03-Apr-2023 | ||
| US-20250134940-A1 | Compositions and methods for the treatment of skin diseases and conditions including eczema | Active | 03-Apr-2023 | ||
| US-20260335384-A1 | Compositions and methods for the treatment of skin diseases and conditions including eczema | Pending | 03-Apr-2023 | A61K35/76 |
Phi Therapeutics (California) Signals
Phi Therapeutics (California) Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Lift Ventures | Accelerator/Incubator | Minority | ||
| Maximum Effort | Corporation | Minority | ||
| N Plus One Ventures | Venture Capital | Minority | ||
| Squared Circles | VC-Backed Company | Minority |
Phi Therapeutics (California) FAQs
-
When was Phi Therapeutics (California) founded?
Phi Therapeutics (California) was founded in 2014.
-
Where is Phi Therapeutics (California) headquartered?
Phi Therapeutics (California) is headquartered in Petaluma, CA.
-
What is the size of Phi Therapeutics (California)?
Phi Therapeutics (California) has 10 total employees.
-
What industry is Phi Therapeutics (California) in?
Phi Therapeutics (California)’s primary industry is Personal Products.
-
Is Phi Therapeutics (California) a private or public company?
Phi Therapeutics (California) is a Private company.
-
What is Phi Therapeutics (California)’s current revenue?
The current revenue for Phi Therapeutics (California) is .
-
How much funding has Phi Therapeutics (California) raised over time?
Phi Therapeutics (California) has raised $9.2M.
-
Who are Phi Therapeutics (California)’s investors?
, Lift Ventures, Maximum Effort, N Plus One Ventures, and Squared Circles are 5 of 14 investors who have invested in Phi Therapeutics (California).
-
Who are Phi Therapeutics (California)’s competitors?
Dermala, Oskia Skincare, AHAVA, It Cosmetics, and La Roche Posay are some of the 9 competitors of Phi Therapeutics (California).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process